CD84 as a Prognostic Biomarker and Therapeutic Target in Breast Cancer - Interconnections With PDL1, CD74, and Immune Tolerance Mechanisms
Favorite
Share
More Options
7

Open in WPS to view all 7 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
